Agios Pharmaceuticals
AGIO
AGIO
163 hedge funds and large institutions have $1.99B invested in Agios Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 68 increasing their positions, 36 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
36% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 25
5% more funds holding
Funds holding: 155 → 163 (+8)
Holders
163
Holding in Top 10
7
Calls
$60.5M
Puts
$31.6M
Top Buyers
| 1 | +$39M | |
| 2 | +$31.4M | |
| 3 | +$27.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$25.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.5M |
Top Sellers
| 1 | -$74.7M | |
| 2 | -$9.23M | |
| 3 | -$8.61M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.85M |